Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study
British Journal of Dermatology · 2024
DOI: 10.1093/bjd/ljae013 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Jesús Peña-Martín und 13 weiteren Autor:innen. Beteiligte Einrichtung: Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM). Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III, Junta de Andalucía.
Abstract (Originalsprache)
Background
Malignant melanoma (MM) is a highly aggressive form of skin cancer whose incidence continues to rise worldwide. If diagnosed at an early stage, it has an excellent prognosis, but mortality increases significantly at advanced stages after distant spread. Unfortunately, early detection of aggressive melanoma remains a challenge.
Objectives
To identify novel blood-circulating biomarkers that may be useful in the diagnosis of MM to guide patient counselling and appropriate disease management.
Methods
In this study, 105 serum samples from 26 healthy patients and 79 with MM were analysed using an untargeted approach by liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS) to compare the metabolomic profiles of both conditions. Resulting data were subjected to both univariate and multivariate statistical analysis to select robust biomarkers. The classification model obtained from this analysis was further validated with an independent cohort of 12 patients with stage I MM.
Results
We successfully identified several lipidic metabolites differentially expressed in patients with stage I MM vs. healthy controls. Three of these metabolites were used to develop a classification model, which exhibited exceptional precision (0.92) and accuracy (0.94) when validated on an independent sample.
Conclusions
These results demonstrate that metabolomics using LC-HRMS is a powerful tool to identify and quantify metabolites in bodily fluids that could serve as potential early diagnostic markers for MM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM).
- Department of Human Anatomy and Embryology, Faculty of Medicine.
- Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.
- Excellence Research Unit "Modeling Nature" (MNat).
- Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía. Parque Tecnológico Ciencias de la Salud, Granada, Spain.
- Department of Biochemistry 3 and Immunology, Faculty of Medicine.
ORCID-Profile: Juan Antonio Marchal
Förderung
- Ministerio de Ciencia e Innovación
- Instituto de Salud Carlos III
- Junta de Andalucía
Zitieren
APA
Peña-Martín, J., Belén García-Ortega, M., Palacios-Ferrer, J. L., Díaz, C., Ángel García, M., Boulaiz, H., Valdivia, J., Jurado, J. M., Almazan-Fernandez, F. M., Arias Santiago, S., Vicente, F., Del Val, C., Pérez Del Palacio, J., & Marchal, J. A. (2024). Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae013
Vancouver
Peña-Martín J, Belén García-Ortega M, Palacios-Ferrer JL, Díaz C, Ángel García M, Boulaiz H, et al. Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae013
BibTeX
@article{PeaMartn2024,
author = {Peña-Martín, Jesús and Belén García-Ortega, María and Palacios-Ferrer, José Luis and Díaz, Caridad and Ángel García, María and Boulaiz, Houria and Valdivia, Javier and Jurado, José Miguel and Almazan-Fernandez, Francisco M and Arias Santiago, Salvador and Vicente, Francisca and Del Val, Coral and Pérez Del Palacio, José and Marchal, Juan Antonio},
title = {Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study},
journal = {British Journal of Dermatology},
year = {2024},
doi = {10.1093/bjd/ljae013}
}
EUVIMED